These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 2422013

  • 41. Antiestrogen pharmacology and mechanism of action.
    Katzenellenbogen BS, Miller MA, Eckert RL, Sudo K.
    J Steroid Biochem; 1983 Jul; 19(1A):59-68. PubMed ID: 6887873
    [Abstract] [Full Text] [Related]

  • 42. Modulation of tamoxifen-specific binding sites and estrogen receptors by estradiol and progesterone in the neonatal uterus of guinea pig.
    Gulino A, Pasqualini JR.
    Endocrinology; 1983 May; 112(5):1871-3. PubMed ID: 6832074
    [Abstract] [Full Text] [Related]

  • 43. Ligand-receptor dissociation: a potential mechanism for the attenuation of estrogen action in the juvenile rabbit uterus.
    Chilton BS, Williams ND, Cobb AD, Leavitt WW.
    Endocrinology; 1987 Feb; 120(2):750-7. PubMed ID: 3803303
    [Abstract] [Full Text] [Related]

  • 44. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
    Reiner GC, Katzenellenbogen BS, Bindal RD, Katzenellenbogen JA.
    Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
    [Abstract] [Full Text] [Related]

  • 45. Antiestrogen(4-hydroxytamoxifen)-charged estrogen receptor binding to nuclei from normal and neoplastic rat mammary tissues is not affected by host hormonal status.
    Klinge CM, Knox DT, Bambara RA, Zain S, Hilf R.
    J Steroid Biochem; 1989 Sep; 33(3):335-40. PubMed ID: 2779224
    [Abstract] [Full Text] [Related]

  • 46. Distribution of estrogen receptors in hen oviduct chromatin fractions in the course of DNAase II digestion.
    Hemminki K, Vauhkonen M.
    Biochim Biophys Acta; 1977 Jan 03; 474(1):109-16. PubMed ID: 831807
    [Abstract] [Full Text] [Related]

  • 47. Evidence for biological action of the antiestrogens LY117018 and tamoxifen by different mechanisms.
    Black LJ, Goode RL.
    Endocrinology; 1981 Sep 03; 109(3):987-9. PubMed ID: 7262030
    [Abstract] [Full Text] [Related]

  • 48. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth.
    Coezy E, Borgna JL, Rochefort H.
    Cancer Res; 1982 Jan 03; 42(1):317-23. PubMed ID: 7053859
    [Abstract] [Full Text] [Related]

  • 49. Multiple forms of nuclear estrogen receptor in the immature rat uterus after in vitro exchange with [3H]estradiol or [3H] antiestrogens.
    Attardi B.
    Mol Cell Endocrinol; 1983 Feb 03; 29(2):159-67. PubMed ID: 6832469
    [No Abstract] [Full Text] [Related]

  • 50. Interactions of oestradiol-17beta and tamoxifen in the uterus of the pregnant rat.
    Major JS, Green B, Heald PJ.
    J Endocrinol; 1976 Dec 03; 71(3):315-24. PubMed ID: 1003061
    [Abstract] [Full Text] [Related]

  • 51. A monoclonal antibody to the estrogen receptor discriminates between the nonactivated and activated estrogen- and anti-estrogen-receptor complexes.
    Borgna JL, Fauque J, Rochefort H.
    Biochemistry; 1984 May 08; 23(10):2162-8. PubMed ID: 6733078
    [Abstract] [Full Text] [Related]

  • 52. Nuclear acceptor sites for estrogen-receptor complexes in the liver of the turtle, Chrysemys picta. I. Sexual differences, species specificity and hormonal dependency.
    Yu MS, Ho SM.
    Mol Cell Endocrinol; 1989 Jan 08; 61(1):37-48. PubMed ID: 2744216
    [Abstract] [Full Text] [Related]

  • 53. Hypothalamic, pituitary and uterine cytoplasmic and nuclear oestrogen receptors and their relationship to the serum concentration of tamoxifen and its metabolite, 4-hydroxytamoxifen, in the ovariectomized rat.
    Bowman SP, Leake A, Morris ID.
    J Endocrinol; 1982 Aug 08; 94(2):167-75. PubMed ID: 7108408
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen.
    Danielian PS, White R, Hoare SA, Fawell SE, Parker MG.
    Mol Endocrinol; 1993 Feb 08; 7(2):232-40. PubMed ID: 8469236
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Estradiol and tamoxifen interaction at receptor sites at 37 C.
    Fishman JH.
    Endocrinology; 1983 Sep 08; 113(3):1164-6. PubMed ID: 6191968
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Inhibition of uterine estrogen receptor transformation by sodium molybdate.
    Shyamala G, Leonard L.
    J Biol Chem; 1980 Jul 10; 255(13):6028-31. PubMed ID: 7391003
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.